Yüklüyor......

Combination of a Hepatitis C Virus NS3-NS4A Protease Inhibitor and Alpha Interferon Synergistically Inhibits Viral RNA Replication and Facilitates Viral RNA Clearance in Replicon Cells

The present standard of care for hepatitis C virus (HCV) infection is pegylated alpha interferon (IFN-α) in combination with ribavirin. However, specific antivirals such as HCV NS3-NS4A protease inhibitors are now in clinical development, and these agents can potentially be used in combination with...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Lin, Kai, Kwong, Ann D., Lin, Chao
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: American Society for Microbiology 2004
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC529208/
https://ncbi.nlm.nih.gov/pubmed/15561857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1128/AAC.48.12.4784-4792.2004
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!